Successful treatment with ustekinumab for corticosteroid-and immunosuppressant-resistant Takayasu's arteritis

R Yachoui, M Kreidy, M Siorek… - Scandinavian Journal of …, 2018 - Taylor & Francis
Takayasu's arteritis (TAK) is an idiopathic large-vessel vasculitis that usually affects young
females (1). Glucocorticoids are the mainstay of treatment for TAK, although relapses occur …

Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application

C Terao, H Yoshifuji, T Nakajima… - Scandinavian journal …, 2016 - Taylor & Francis
Takayasu arteritis (TAK) is a systemic vasculitis affecting the large arteries (1).
Glucocorticoids and immunosuppressants including biological agents targeting tumour …

Successful treatment of refractory Takayasu arteritis with tacrolimus

H Yamazaki, T Nanki, M Harigai… - The Journal of …, 2012 - jrheum.org
Takayasu arteritis (TA) is a systemic vasculitis that affects large-size vessels such as the
aorta and/or its main branches. Persistent inflammation of TA leads to segmental stenosis …

Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?

A Della Rossa, A Tavoni, G Merlini, C Baldini… - …, 2005 - academic.oup.com
SIR, Takayasu arteritis (TA) is a chronic, idiopathic, inflammatory disease that primarily
affects large vessels [1]. The management of this disorder is largely unresolved, since a …

Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis

SJ Saur, M Horger, J Henes - Rheumatology Advances in …, 2021 - academic.oup.com
Dear Editor, Takayasu arthritis is a systemic vasculitis affecting the large arteries [1], typically
in young women. The first-line approach is the use of high-dose CSs, which can be …

[PDF][PDF] Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: results of a multicenter open-label prospective study

P Mertz, JF Kleinmann, M Lambert, X Puéchal… - Autoimmunity …, 2020 - Elsevier
Takayasu arteritis (TA) is a chronic large vessel vasculitis affecting predominantly the aorta
45 and its main branches, as well as the pulmonary arteries (1, 2). Of unknown origin (3) …

Takayasu arteritis: active or not, that's the question

A Dikkes, M Aschwanden, S Imfeld, K Glatz… - …, 2017 - academic.oup.com
SIR, a 30-year-old woman with left sided brachiofascial hemiparesis, pre-existing fatigue
and progressive and fluctuating blurred vision presented at our emergency room. The ESR …

Interleukin 6 targeting in refractory Takayasu arteritis: serial noninvasive imaging is mandatory to monitor efficacy

T Youngstein, JC Mason - The Journal of Rheumatology, 2013 - jrheum.org
Takayasu arteritis (TA) is a true orphan disease. There are no published controlled clinical
trials and the evidence on which to develop management strategies and therapeutic …

Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis

A Ferrante, F Ciccia, G Guggino… - Scandinavian journal …, 2016 - Taylor & Francis
A 46-year-old female Caucasian patient was referred to our unit with upper extremity
claudication, dyspnoea [New York Heart Association (NYHA) Class III], and weight loss. On …

Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab

Y Gon, H Yoshifuji, T Nakajima… - Modern …, 2021 - academic.oup.com
Objectives Biologics have been used to treat refractory Takayasu arteritis (TAK), but their
efficacy and safety have not been sufficiently evaluated. Methods We extracted clinical …